As we approach March 20, 2026, the Indian market is not just watching a patent expire
Oral semaglutide acts as a keystone therapy because treating obesity often leads to significant improvements in these other conditions
Food and Drug Administration (FDA)-approved glucagon-like peptide-1 receptor agonists (GLP-1) anti-obesity medications, such as Zepbound and Wegovy , are flying off pharmacy shelves
A Motion to Compel will be filed by the PLG if this issue remains unresolved
10.2147/DDDT.S381546 59 ReunanenJ.KainulainenV.HuuskonenL.OttmanN.BelzerC.HuhtinenH.et al (2015)
It is supposed to be a scientifically rigorous document, so that when you tell the school lunch program you cant serve whole milk, you have to buy 1% or 2% or skim, there is a scientific document that backs up that rationale